RETRACTABLE TECHNOLOGIES INC (RVP) stock: key figures, P/E, revenue and dividend

Health Care · United States · ISIN US76129W1053

Price
0.58 USD
Market cap
17.24 m USD
P/E (2026)
–
P/S (2026)
–
Dividend yield
0.00 %
Net margin
–
Return on equity (ROE)
–
Return on assets (ROA)
–

RETRACTABLE TECHNOLOGIES INC financials

Fiscal year2025
Revenue38.27 m USD
Gross profit47,046.00 USD
Operating income-21.18 m USD
EBIT-12.19 m USD
Net income-12.57 m USD
Diluted EPS – continuing operations-0.43 USD

Full history since 2000, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About RETRACTABLE TECHNOLOGIES INC

Retractable Technologies, Inc. designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession in the United States, rest of North and South America, and internationally. The company offers VanishPoint insulin syringes; tuberculin, insulin, and allergy antigen syringes; small diameter tube adapters; blood collection tube holders; allergy trays; IV safety catheters; Patient Safe syringes and Luer Caps; VanishPoint blood collection sets; EasyPoint needles; and VanishPoint autodisable syringes. It distributes its products through general line and specialty distributor; international distributors; and national direct marketing network. Retractable Technologies, Inc. was incorporated in 1994 and is headquartered in Little Elm, Texas.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.